cms_WV: 5605

In collaboration with The Seattle Times, Big Local News is providing full-text nursing home deficiencies from Centers for Medicare & Medicaid Services (CMS). These files contain the full narrative details of each nursing home deficiency cited regulators. The files include deficiencies from Standard Surveys (routine inspections) and from Complaint Surveys. Complete data begins January 2011 (although some earlier inspections do show up). Individual states are provides as CSV files. A very large (4.5GB) national file is also provided as a zipped archive. New data will be updated on a monthly basis. For additional documentation, please see the README.

Data source: Big Local News · About: big-local-datasette

This data as json, copyable

rowid facility_name facility_id address city state zip inspection_date deficiency_tag scope_severity complaint standard eventid inspection_text filedate
5605 ELDERCARE HEALTH AND REHABILITATION 515065 107 MILLER DRIVE RIPLEY WV 25271 2015-04-10 428 D 0 1 QSV111 **NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on record review and staff interview, the facility failed to ensure a licensed pharmacist reviewed each resident's medication regimen at least monthly, and the pharmacist failed to identify and report a medication irregularity to the attending physician and the Director of Nursing. An allergy to a prescribed medication was not identified and/or addressed by the pharmacist. In addition, a monthly medication regimen review was not conducted for a resident in (MONTH) 2014. These practices affected one (1) of three (3) residents reviewed for the care area of unnecessary medications. Resident identifier: #21. Facility census: 78. Findings include: a) Resident #21 On 04/09/15 at 9:10 a.m., during a review of the physician's orders [REDACTED]. Xanax, a Benzodiazepine medication used to treat Anxiety disorder, was identified as a current medication for the resident. The resident was admitted to the facility on [DATE], and had received Xanax 0.25 mg, one (1) tablet by mouth three (3) times a day since 12/03/13. At 9:20 a.m. on 04/09/15, review of the medical record found no evidence the pharmacist identified and/or addressed the irregularity regarding the resident's allergy to Benzodiazepines, yet the resident was receiving a Benzodiazepine. On 04/09/15 at 2:40 p.m., the Administrator and the Director of Nursing (DON) were made aware of the findings regarding the resident's listed allergy to Benzodiazepines, when receiving a Benzodiazepine as part of her medication regimen. The administrator and the DON were asked to provide evidence the pharmacist identified the irregularity regarding the allergy and the prescribed medication. No evidence was provided by the completion of the Quality Indicator Survey (QIS). In addition, review of the medical record, at 10:35 a.m. on 04/09/15, identified no evidence of a medication regimen review by the pharmacist, for Resident #21, for the month of (MONTH) 2014. At 11:00 a.m. on 04/09/15, the Administrator and the DON were made aware of the findings regarding the monthly medication regimen review for the resident for the month of (MONTH) 2014. By the completion of the survey, neither provided evidence of a (MONTH) 2014 medication regimen review by the pharmacist. 2018-09-01